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Background: Phyllodes tumours (PT) are rare and distinct breast tumours, which span a 
morphological continuum. Classification into benign, borderline and malignant categories 
reflects their biology and clinical behaviour and is essential to guide management. This study 
aims to assess the diagnostic agreement of PT using the UK National Health Service Breast 
Screening Programme (NHSBSP) breast pathology external quality assurance (EQA) scheme 
data. 
Methods: 26 PTs were identified in the EQA scheme, which were diagnosed by an average of 
607 participants/circulation. Data on diagnostic categories were collected, and representative 
slides were reviewed. The level of concordance between reporting pathologists was assessed.  
Results: There were 14 benign, 6 borderline and 6 malignant PT. The overall rate of diagnosis 
agreement was 86% when analysed as benign lesions, borderline PT and malignant lesions, 
which decreased to 79% when diagnosed as PT (irrespective of grade) and to 63% when the 
diagnosis was further refined to PT categories (benign, borderline and malignant PTs). The 
highest agreement rate was observed in malignant PT (86%) and the lowest in borderline PT 
(42%). Malignant heterologous elements, stromal overgrowth and leaf-like architecture are 
features associated with higher concordance rates. Lower priority features were stromal 
expansion, clefting, and multinodularity. 
Conclusion: The concordance of PT diagnosis, as an entity, is high, but its classification into 
benign, borderline and malignant has variable agreement levels, with borderline tumours 
having the lowest concordance rate. More research to refine the diagnostic criteria for 






Phyllodes tumours (PT) are uncommon biphasic (epithelial and stromal) breast lesions 
comprising approximately 1% of all breast tumours. These tumours share the term 
“phyllodes”, which is used to describe their unique architecture; however, they have variable 
morphology, biology and clinical behaviour. PT represent a broad spectrum of lesions from 
indolent benign to aggressive malignant tumours. Adding to the challenge, they overlap with 
entities such as fibroadenoma and hamartoma at the benign end of the spectrum and with 
metaplastic carcinoma and sarcomas at the other end of the spectrum 1,2. Recognition of 
associations between various categories of PTs and risk of recurrence and/or metastasis is 
essential to guide further management. Although distinguishing between classical benign and 
malignant PT is easy and straightforward, tumours with overlapping features make the 
distinction between some forms challenging. Also, classification of PTs depends on a set of 
differently weighted and subjective criteria which results in variability in PTs classification in 
routine practice, potentially impacting on management. PTs are classified into the benign, 
borderline and malignant categories based on a constellation of histological variables 
including the degree of stromal cellularity, stromal cellular atypia, mitotic count, stromal 
overgrowth, and the nature of tumour borders. As each microscopic parameter has two to 
three tiers of stratification, there are significant challenges in obtaining an accurate, objective 
and reproducible categorisation 3.  
 
This study aimed to assess the diagnostic interobserver agreement of PT diagnosis and 
classification utilising a large cohort scored by a large number of pathologists. Cases were 
histologically reviewed to understand the reasons for any disagreement, and to provide 
insights for improving the diagnostic concordance for these tumours. 
 
MATERIALS AND METHODS 
This study is based on data obtained from the National Health Service Breast Screening 
Programme (NHSBSP) external quality assurance (EQA) scheme. A description and details of 
standard operating procedures have been published 4,5. In brief, sets of 12 cases plus three 
educational cases are circulated, twice a year, to pathologists in the UK involved in providing 
breast pathology clinical service. Each case comprises one representative Haematoxylin and 
Eosin (H&E) stained slide of surgical excision specimens. The cases are submitted by 




includes the diagnostic classification of the lesion. The scheme includes >700 UK- and Republic 
of Ireland - based participants, and each participating pathologist independently examines 
the slide for each case and completes a tick-box proforma. Participants included breast 
specialists and non-specialists (general pathologists with interest in breast pathology).  
 
In this study, a total number of 26 PT cases were retrieved. These cases had been circulated 
over 17 years, between 2003 and 2019 and were assessed by an average of 607 pathologists 
(range 454 - 675). Slides from these lesions were reviewed under a multi-head microscope by 
4 pathologists specialising in breast pathology (ER, RM, AA, MT) to agree on final classification 
of the lesion based on current diagnostic criteria agreed by World Health Organisation (WHO) 
6,7. Morphological features were systematically recorded as follows: 1) tumour border (well-
defined/focally infiltrative/infiltrative), 2) architecture (leaf-like/clefts/absent characteristic 
architecture), 3) sub-epithelial stromal condensation (yes/no), 4) stromal cellularity 
(mild/moderate/marked), 5) highest degree of cellularity (in cases with heterogeneous 
appearance), 6) extent of hypercellularity (diffuse/focal), 7) degree of stromal atypia 
(absent/mild/moderate/marked), 8) mitotic activity (number of mitoses/10 high power fields 
(HPF)), 9) presence of atypical mitoses (yes/no), 10) stromal overgrowth (yes/no), 11) 
malignant heterologous elements (present/absent), 12) benign stromal metaplasia (e.g., 
chondroid, osseous and myoid metaplasia) (yes/no), 13) necrosis (present/absent), tissue 
infarction was not recorded as necrosis (Figure 1), and 14) epithelial atypia (yes/no). In this 
study, stromal overgrowth was defined as stromal proliferation without epithelial elements 
observed in at least one low-power field (4x microscope objective) 6. Predominance of stroma 
with increased stromal areas without epithelium but less than that defined as overgrowth 
was classified as stromal expansion. We have also introduced a few other less reported or 
studied features. Multinodularity was recorded when either multiple or small satellite 
nodules were seen in the periphery of the lesion; these were either poorly or well-defined 
areas of stromal or biphasic proliferation (Figure 2). Clefting was defined as the presence of 
elongated, branching ducts with a staghorn appearance and it was recorded in cases where 
the well-developed leaf-like architecture was absent 7 (Figure 3). 
 
Case classification into one of the four EQA diagnostic categories (benign/atypia/in 




text answers) was available for each case. As such, benign PTs were sometimes diagnosed as 
fibroadenoma or benign fibroepithelial proliferation and grouped under benign lesions. 
Similarly, malignant PTs were sometimes labelled as soft tissue sarcomas or metaplastic 
carcinomas and grouped under malignant lesions. Borderline phyllodes tumours were 
sometimes added under benign / atypia / in situ categories. The agreement rate was first 
calculated based on this initial EQA grouping as either benign lesions, borderline PT or 
malignant lesions. 
A case-by-case analysis was performed to accurately record all replies, regardless of how they 
were initially assigned to one of the 4 EQA diagnostic categories. Actual concordance rates 
were then calculated as the percentage of respondents who agreed with the final diagnosis. 
Cases were again reviewed based on their true diagnostic agreements rates, and reasons for 
concordance/discordance were discussed and detailed. The final “ground truth” diagnosis for 
each case was based on the majority diagnosis of members of the EQA scheme central 
coordinating group of pathologists, approximately 20 in number, representing each English 
NHS health region and the devolved UK nations plus 2 representatives from the Republic of 
Ireland. This final “consensus diagnosis” was confirmed at review discussion by the authors 
(pathologists) of this study. Borderline PTs that showed a split of the diagnosis between 
benign and malignant PTs were considered in this study as borderline PT.  
The morphological features recorded for discordant cases were analysed against cases with 
good concordance to reveal areas of confusion and possible pitfalls; this helped reveal 
morphological features easily recognized from more subtle changes which had a lower impact 
on final diagnosis.  
 
RESULTS 
Following the review of the reported diagnoses and of the representative slides, cases were 
classified into benign (n=14), borderline (n=6) and malignant (n=6) PTs. The diagnostic 
agreement rate of these cases varied significantly when different diagnostic categories were 
considered (Table 1). A higher agreement rate was obtained when the cases were classified 
as “benign lesions” versus borderline PT versus “malignant lesions” (86%) compared to when 
classified as 3 PT grades (benign, borderline or malignant PTs) (63%). The diagnostic 
agreement of all cases diagnosed as PT irrespective of its grade was 79% (ranged 41% to 99%). 




in 91% of cases. When the term benign PT was used as a final diagnosis, the concordance rate 
when compared to the ground truth diagnosis decreased to 86%. Similar concordance rates 
were observed with malignant PT (90%), whereas the lowest concordance rates were found 
in borderline PT (42%) (Table 1).  
 
The benign category included benign PT as well as other benign diagnoses made by 
participating pathologists in each case. In benign PT, other benign diagnoses comprised 25% 
(range 3%-44%) of the cases. These included other benign fibroepithelial lesions: 
fibroadenoma (which was the most common diagnosis), followed by hamartoma, 
fibroadenomatoid hyperplasia and benign fibroepithelial lesion, unclassified in addition to 
occasional cases reported as pseudoangiomatous stromal hyperplasia (PASH) and 
fibromatosis. The term benign fibroepithelial lesions was not frequently used (reported 45 
times in the whole series). In cases of malignant PTs, they were largely assigned to the 
malignant category; other diagnoses specifically named by participants for these lesions 
included sarcoma and metaplastic carcinoma.  
 
Benign PT  
Although benign PT had variable agreement levels, the diagnosis of malignancy was very rare 
apart from one case, which was diagnosed as malignant PT by 13% of the participants. The 
other diagnoses reported by participants included other benign entities followed by 
borderline PT.  
 
In the benign PT group, we found that cases with features overlapping between fibroadenoma 
and benign PT were unlikely to be diagnosed as borderline or malignant PT. In contrast, benign 
PTs with more borderline appearances were less likely to be diagnosed as fibroadenoma. 
These features included hypercellularity, leaf-like architecture and prominent clefting, even 
in the absence of stromal atypia or in the presence of low stromal mitotic activity.  
 
One benign PT showed fat infiltration, which on histological review appeared to represent 




areas of the same tumour showed changes of benign PT with stromal expansion and clefting. 
This case was classified as fibroadenoma, hamartoma or fibroadenomatoid changes by 44% 
of the participants, rather than recognised as benign PT.  
 
Another case showed myoid differentiation resulting in increased cellularity (mild to 
moderate stromal cellularity) that distorted the predominantly pericanalicular growth 
pattern, resulting in lack of leaf-like architecture, focally ill-defined margins and no stromal 
atypia or mitosis. This case was diagnosed as benign PT by 48% of the participants, while the 
remaining classified it as: fibroadenoma (16%), hamartoma (6%), fibromatosis (8%), and 
benign fibroepithelial lesion, unclassified (1%); other benign entities including spindle cell 
tumour, adenomyoepithelioma and myofibroblastoma were reported by 13% of pathologists.  
 
On review of a case of benign PT that was diagnosed as fibroadenoma in 36% and benign PT 
in 64%, there was significant stromal hypocellularity in areas of stromal expansion, and no 
obvious atypia or mitotic activity was seen. However, the presence of clefting and stromal 
expansion were sufficient for the diagnosis of benign PT.  
 
Interestingly, one benign PT showed stromal changes in keeping with cellular PASH resulting 
in an appearance of a diffuse mild to moderate stromal cellularity with worrisome spindle cell 
proliferation. Clefting was focal and the margin was focally infiltrative. This case yielded the 
lowest concordance of the benign PT (19%) and multiple diagnoses were given including other 
benign fibroepithelial lesion in 3%, benign lesion without further description in 33%, 
fibromatosis in 5%, borderline PT in 9% and even malignant in 34% (including malignant PT in 
13% and angiosarcoma in 8%), even though atypia was mild to moderate, mitotic counts were 
low (3/10HPF) and no atypical mitoses or malignant heterologous elements were noticed.  
 
Lastly, one case showed prominent classical type PASH like changes and PASH was reported 







Borderline PT showed the lowest concordance rates. In borderline PTs, the second most 
preferred diagnosis was benign PT in most cases. Borderline PTs showing low concordance 
rates, below 50% were classified as such by participants following histological review. The 
principal cause of low concordance rate was a split of diagnoses proffered between benign 
PT and malignant PT (Table 2). The borderline PT that showed the lowest concordance rate 
had a marked atypical lipomatous component which resulted in confusion during reporting, 
as explained below, with a high rate of both malignant and benign diagnoses made. The 
borderline PT with the highest level of agreement in our series had a 66% diagnostic 
concordance, with another 17% of respondents opting for benign PT, 8% for malignant PT and 
6% for fibroadenoma. This case had marked stromal hypercellularity and a high mitotic count 
of up to 10 mitoses/10HPF.  
 
Malignant PT 
Malignant PT were generally correctly assigned as malignant (Table 1). The presence of 
malignant heterologous elements was associated with the highest concordance of reporting 
malignant PT. However, other diagnoses were proffered including sarcoma, invasive breast 
carcinoma of no special type (IBC-NST), mucinous carcinoma and other malignant lesions. The 
epithelial proliferation in some cases lead to an erroneous diagnosis of ductal carcinoma in 
situ (DCIS), adenomyoepithelioma or invasive carcinoma in few cases. On review, the 
epithelium appeared proliferative, but reactive and metaplastic in nature rather than 
neoplastic.  
 
One malignant PT showed features overlapping between borderline and malignant PT. This 
case had a focal well-differentiated liposarcomatous component and bizarre multinucleated 
stromal giant cells. The presence of a liposarcomatous component had an impact on 
diagnostic agreement. We found, 2 cases of malignant PT showing lipoblastic component, but 
with high nuclear grade atypia in keeping with pleomorphic liposarcoma rather than the well-
differentiated liposarcoma (Figure 4); the latter component, if present, is now considered 
insufficient for the diagnosis of malignancy in PT on its own 7. One malignant PT with a well-




recommendation and this case also had additional features that favoured the diagnosis of 
malignant PT. One recent case with a well-differentiated liposarcomatous component, but no 
other malignant features had a split of proffered diagnoses between malignant and benign 
(Table 2).  
 
Only 1 out of the 6 malignant PT had diagnostic agreement under 80%; we believe this may 
be a consequence of uncertainty over the nature of multinucleated giant cells present in the 
stroma (Figure 5). In this case, the next most frequent diagnosis was in the benign category 
(13%) rather than borderline PT (6%). 
 
Good concordance PT 
There were 6 cases that showed diagnostic agreement over 80%, which included 5 malignant 
(98%, 98%, 91%, 81% and 80%) and one benign (81%) PTs. The 5 malignant cases showed 
marked stromal atypia. Three of these cases exhibited malignant heterologous elements 
(chondrosarcoma, osteosarcoma and/or pleomorphic/high grade liposarcoma), while the 
other 2 showed high mitotic counts (18 and 19/10HPF respectively) with multiple atypical 
Figures. All cases showing atypical mitoses were in the high concordance groups, with one 
exception where cellular areas were poorly represented on the slide. 
 
The benign PT with 81% agreement between participants, had variable stromal cellularity 
with areas of moderate to marked increased cellularity, focal clefting, but no stromal 
overgrowth, 3 mitoses/10HPF, and mild to moderate stromal atypia. The margins were well 
defined. The consensus meeting favoured benign over borderline PT (diagnosed in 15%), 
rather than fibroadenoma (diagnosed in 3%) or malignant PT (1%). 
Morphological features associated with diagnostic discordance 
Diagnostic discordance (<60%) was observed in 87% (7/8) of borderline PT and 58% (7/12) of 
benign PT. The lowest concordance case was a borderline PT, which showed intermediate 
morphological features or non-uniform changes in terms of cellularity, atypia and architecture 
(Figure 6). All these borderline PT cases showed features overlapping with other categories. 




mimicking benign PT. Additionally, on low magnification, 3 of these 5 borderline PT showed a 
hypocellular appearance, with oedema or PASH-like changes in areas of stromal expansion. 
The benign PT with low concordance had focal or no clefting, non-uniform stromal cellularity, 
and lacked stromal overgrowth or well-formed leaf-like structures.  
 
Multinodularity was seen in 7 cases, 4 of which were in the discordant groups. All cases with 
multinodularity from our series also had at least focally infiltrative margins and were classified 
as either borderline or malignant PT.  
 
Towards the benign end of the spectrum of fibroepithelial lesions, there were 10 cases of 
benign PT for which the other main diagnosis was a benign entity, mostly fibroadenoma. 
Almost all these cases showed epithelial clefting but no leaf-like structures (7/10), well-
defined margins (8/10), focal increase in stromal cellularity (5/10) and stromal expansion but 
no overgrowth (6/10).  
 
Estimating the degree of stromal atypia in PT is a subjective task. Most cases (83%) with a 
concordance in between 40% to 80% had absent or mild stromal atypia and a main differential 
diagnosis with fibroadenoma or other benign entities. Marked stromal atypia was usually 
seen in the unequivocal malignant PT cases. 
 
DISCUSSION 
PT of the breast remains a controversial entity, not only regarding its clinical management, 
but also its diagnostic histological features and categorisation 6. This study showed variation 
in the level of diagnostic agreement of PT and identified a range of other confounding lesion 
frequently reported by pathologists. Additional histological review of the slides, as a 
component of this study, has enabled identification of features which may explain the high 
and low agreement rates observed and which could be used to signal cases that may require 
a second opinion or further diagnostic workup. As this study was based on the UK EQA scheme 




participating pathologists and based on the published UK NHSBSP and RCPath Guidelines and 
minimum datasets 8-10. 
 
The overall agreement rate in this study appears to be higher than expected, as it is a 
common perception amongst pathologists that PT grading is associated with low 
concordance. However, this study showed that discordance rates varied significantly between 
cases. The overall rate of diagnosis agreement was 86% when the data were analysed as 
benign versus borderline PT versus a malignant lesion. It dropped to 79% when the proffered 
diagnosis was restricted to PT (irrespective of grade) and to 63% when the diagnosis was 
based on PT grade. The highest agreement rate was observed in malignant PT and the lowest 
agreement was observed in borderline PT.  
 
For malignant PT the agreement was very good; however, extreme outliers have been 
identified. In some cases, a range of other diagnoses were given including benign PT, 
borderline PT, sarcoma, carcinoma and DCIS, mucinous carcinoma and papillomas. There was 
one malignant PT which, in spite of well represented malignant features, was surprisingly 
classified as benign by 13% of participants. This case serves to highlight that malignant areas 
in PT can be focal, with otherwise benign or borderline characteristics. It may also reflect a 
degree of subjectivity in weighing the various PT diagnostic features by pathologists. 
Pathologists should establish the diagnosis based on the most aggressive areas.  
 
Another observation relates to classification of epithelial proliferation in PT which may mimic 
carcinoma. Although it is understood that PT may be misdiagnosed as metaplastic carcinoma, 
2% and 3% of participants classified 2 malignant PT as carcinoma, of NST and mucinous types. 
Occasionally diagnoses of adenomyoepithelioma and pleomorphic adenoma were proffered. 
Unless the degree of epithelial atypia present is high grade, the diagnosis of DCIS should be 
questioned. Florid and architecturally complex form of benign epithelia hyperplasia are well 
recognised to occur in all fibroepithelial lesion types. In doubtful cases immunohistochemistry 
can be helpful. The stroma in adenomyoepitheliomas is typically not very cellular, and its 





Finally, occasional diagnoses of sarcoma including angiosarcoma, liposarcoma and 
chondrosarcoma were proffered. When the characteristic clefting architecture of PT is 
present, the diagnosis of primary breast sarcoma is essentially excluded. Sarcomatous areas 
within malignant PT are usually biologically different from similar morphological type of 
sarcoma in soft tissue 11,12 and their clinical implications are different. The only benign PT that 
was overcalled as malignant by 24% of participants was associated with prominent and focally 
cellular PASH like areas and focal stromal overgrowth. 
 
Benign PT shows overlapping features with cellular fibroadenoma 1,2 and the distinction is 
especially problematic on core biopsies6,13,14. This study showed that this distinction can also 
be problematic on excision specimens. Fibroadenomas may show mild to moderate degree 
of cellularity, but these cases should not exhibit stromal expansion, overgrowth, leaf-like 
architecture or an infiltrative margin. Classical PT features of epithelial clefting and increased 
stromal cellularity should raise the suspicion of PT, even when these are focal. However, we 
accept that for some cases the distinction is very difficult to make reliably and that opinions 
between pathologists will differ and indeed the outcome and management of such lesions 
may be similar. Use of the term “benign fibroepithelial neoplasm”, when there is histological 
ambiguity, with explanation of the diagnostic difficulty is useful and can avoid overtreatment 
7,15.  
 
Diagnostic agreement of borderline PT is suboptimal, but has the potential to increase 
through guideline improvement focussed on the expanding evidence base, changes in clinical 
management and greater harmonisation of treatment protocols for benign fibroepithelial 
lesions and borderline PT. In routine practice, pathologists should examine multiple slides, 
and process more tissue, which may lead to upgrading some cases to the malignant category. 
In the majority of such borderline cases, seeking the opinion of other pathologists and 
external experts is advised. All these measures are likely to improve the diagnostic agreement 
of such uncommon lesions in the clinical setting. In one case, there was a diagnostic split 
between benign PT and malignant PTs. This case had a well-differentiated lipomatous tumour 
component which was interpreted by some as malignant and ignored by others who made a 
benign diagnosis. This case also showed diffuse moderate stromal cellularity and moderate 
atypia which were sufficient for a borderline PT diagnosis. Current guidelines indicate that 




trying to make a benign or malignant diagnosis. These lesions are likely to be associated with 
higher local recurrences rates, but have much less metastatic potential than malignant PT 
6,7,16. Additionally it is now recommended that the presence of well-differentiated lipomatous 
tumour should not be regarded as a malignant heterologous element that can per se define a 
PT as malignant, 7. However, pleomorphic or high grade liposarcomatous components, 
chondrosarcomatous and/or osteosarcomatous elements, are sufficient on their own to 
designate a PT as malignant.  
 
In this study we found that certain features are associated with better concordance of PT 
diagnosis and classification and that pathologists may prioritise certain features over others 
to reach the overall diagnosis. Lower priority features were stromal expansion, clefting, and 
multinodularity. Malignant heterologous elements, stromal overgrowth and leaf-like 
architecture are features associated with higher concordance rates. Leaf-like processes, a key 
criteria for the diagnosis of PT may be found in intracanalicular fibroadenomas, but in such 
cases they are few in number and often poorly formed 17,18.  
 
We therefore recommend that histological features used to distinguish benign, borderline, 
and malignant PT should be considered holistically, as emphasis on a single feature may result 
in miss-classification 7,19,20. Lack of weighted score rules for these features added to their 
interpretive subjectivity has led to a higher rate of discordance especially in non-
straightforward challenging cases. Strict histological criteria for diagnosing malignant PT, with 
their risk of recurrence and potential, albeit low, for metastatic spread should be adhered to 
in order to avoid under- or overtreatment. Thorough sampling, consultation with colleagues 
and seeking expert opinion in cases of PTs with overlapping features are advised to improve 
the diagnostic agreement. 
 
The strengths of our study are the relatively large cohort of cases available and the large 
number of breast pathologists proffering a diagnosis for each case. One weakness of the study 
is that not all pathologists examined the exact same slide. Although sections are quality 
checked to make sure they are all representative of the lesion before being circulated, this 




on mitotic counts and extent of cellular areas. Also, PTs tend to be morphologically 
heterogeneous, such that a diagnosis based on a single slide may not receive the same 
accuracy when multiple sections of the tumour are examined.  This may have affected the 
diagnostic concordance rates. 
 
In conclusion, the concordance of PT diagnosis, as an entity, is high, but its classification into 
benign, borderline and malignant has variable agreement levels, with borderline tumours 
having the lowest concordance rate. More research to refine the diagnostic criteria for 
categorisation of PT is warranted to improve concordance between pathologists. PT with 
overlapping features should trigger consensus opinion or expert referral. When all else fails, 
it may be prudent to express a degree of uncertainty when reporting lesions with 
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Table 1: Details of concordance rates in different diagnostic categories  












Benign lesion 0.91 0.62-0.98 
Benign PT 0.59 0.19-0.81 
Borderline PT Borderline PT 0.42 0.11-0.66 
Malignant PT 
Malignant tumour 0.90 0.71-0.97 
Malignant PT 0.86 0.67-0.98 
*Measured against all cases included in each circulation. 






Table 2: Spectrum of diagnoses proffered by participants for borderline phyllodes tumours 
(PT) 
 Case 5 Case 3 Case 6 Case 2 Case 1 Case 4 
Diagnosis proffered by participants (%) 
Borderline PT 66 58 55 34 29 11 
Benign PT 17 32 38 30 32 36 
Other benign 10 6 3 4 13 9 
Malignant PT 8 4 4 32 26 45 


























(per 10 HPF) 
10 0 6 22 22 0 
























Multinodularity No Yes No Yes No No 
* Also showed large areas of infarction that impart a hypocellular appearance. 
** shows areas in keeping with well-differentiated liposarcoma / atypical lipomatous tumour. 
None of the cases showed necrosis or malignant heterologous elements 
 
 
